NCT06232616View on ClinicalTrials.gov

Vitrectomy Combined With Intravitreal Dexamethasone Implant for Idiopathic Epiretinal Membrane With Macular Oedema

NAEnrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 11, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Epiretinal Membrane
Interventions
PROCEDURE

vitrectomy combined with intravitreal dexamethasone implant

The dexamethasone implant will be injected into the vitreous cavity at the end of the surgery.

Trial Locations (1)

200040

Shanghai Eye Disease Prevention & Treatment Center, Shanghai

All Listed Sponsors
lead

Shanghai Eye Disease Prevention and Treatment Center

OTHER